Pharmaceuticals

Global Adalimumab Biosimilar Market Research Report 2018

  • QYR2791831
  • 113 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 

This report studies the global Adalimumab Biosimilar market status and forecast, categorizes the global Adalimumab Biosimilar market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report

AET BioTech

Amgen

Boehringer Ingelheim

Coherus Biosciences

Fujifilm Kyowa Kirin Biologics

LG Life Sciences/Mochida Pharmaceutical

Momenta Pharmaceuticals

Oncobiologics

Pfizer

Samsung Bioepsis

Sandoz

Zydus Cadila

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

Southeast Asia

India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Tablet

Oral Solution

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

The study objectives of this report are:

To analyze and study the global Adalimumab Biosimilar capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

Focuses on the key Adalimumab Biosimilar manufacturers, to study the capacity, production, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Adalimumab Biosimilar are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Adalimumab Biosimilar Manufacturers

Adalimumab Biosimilar Distributors/Traders/Wholesalers

Adalimumab Biosimilar Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Adalimumab Biosimilar market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Adalimumab Biosimilar Market Research Report 2018

1 Adalimumab Biosimilar Market Overview

1.1 Product Overview and Scope of Adalimumab Biosimilar

1.2 Adalimumab Biosimilar Segment by Type (Product Category)

1.2.1 Global Adalimumab Biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)

1.2.2 Global Adalimumab Biosimilar Production Market Share by Type (Product Category) in 2017

1.2.3 Tablet

1.2.3 Oral Solution

1.3 Global Adalimumab Biosimilar Segment by Application

1.3.1 Adalimumab Biosimilar Consumption (Sales) Comparison by Application (2013-2025)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Adalimumab Biosimilar Market by Region (2013-2025)

1.4.1 Global Adalimumab Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)

1.4.2 North America Status and Prospect (2013-2025)

1.4.3 Europe Status and Prospect (2013-2025)

1.4.4 China Status and Prospect (2013-2025)

1.4.5 Japan Status and Prospect (2013-2025)

1.4.6 Southeast Asia Status and Prospect (2013-2025)

1.4.7 India Status and Prospect (2013-2025)

1.5 Global Market Size (Value) of Adalimumab Biosimilar (2013-2025)

1.5.1 Global Adalimumab Biosimilar Revenue Status and Outlook (2013-2025)

1.5.2 Global Adalimumab Biosimilar Capacity, Production Status and Outlook (2013-2025)

2 Global Adalimumab Biosimilar Market Competition by Manufacturers

2.1 Global Adalimumab Biosimilar Capacity, Production and Share by Manufacturers (2013-2018)

2.1.1 Global Adalimumab Biosimilar Capacity and Share by Manufacturers (2013-2018)

2.1.2 Global Adalimumab Biosimilar Production and Share by Manufacturers (2013-2018)

2.2 Global Adalimumab Biosimilar Revenue and Share by Manufacturers (2013-2018)

2.3 Global Adalimumab Biosimilar Average Price by Manufacturers (2013-2018)

2.4 Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution, Sales Area and Product Type

2.5 Adalimumab Biosimilar Market Competitive Situation and Trends

2.5.1 Adalimumab Biosimilar Market Concentration Rate

2.5.2 Adalimumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Adalimumab Biosimilar Capacity, Production, Revenue (Value) by Region (2013-2018)

3.1 Global Adalimumab Biosimilar Capacity and Market Share by Region (2013-2018)

3.2 Global Adalimumab Biosimilar Production and Market Share by Region (2013-2018)

3.3 Global Adalimumab Biosimilar Revenue (Value) and Market Share by Region (2013-2018)

3.4 Global Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.5 North America Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.6 Europe Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.7 China Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.8 Japan Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.9 Southeast Asia Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

3.10 India Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Adalimumab Biosimilar Supply (Production), Consumption, Export, Import by Region (2013-2018)

4.1 Global Adalimumab Biosimilar Consumption by Region (2013-2018)

4.2 North America Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

4.3 Europe Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

4.4 China Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

4.5 Japan Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

4.6 Southeast Asia Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

4.7 India Adalimumab Biosimilar Production, Consumption, Export, Import (2013-2018)

5 Global Adalimumab Biosimilar Production, Revenue (Value), Price Trend by Type

5.1 Global Adalimumab Biosimilar Production and Market Share by Type (2013-2018)

5.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2013-2018)

5.3 Global Adalimumab Biosimilar Price by Type (2013-2018)

5.4 Global Adalimumab Biosimilar Production Growth by Type (2013-2018)

6 Global Adalimumab Biosimilar Market Analysis by Application

6.1 Global Adalimumab Biosimilar Consumption and Market Share by Application (2013-2018)

6.2 Global Adalimumab Biosimilar Consumption Growth Rate by Application (2013-2018)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Adalimumab Biosimilar Manufacturers Profiles/Analysis

7.1 AET BioTech

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Adalimumab Biosimilar Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 AET BioTech Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.1.4 Main Business/Business Overview

7.2 Amgen

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Adalimumab Biosimilar Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Amgen Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.2.4 Main Business/Business Overview

7.3 Boehringer Ingelheim

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Adalimumab Biosimilar Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Boehringer Ingelheim Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.3.4 Main Business/Business Overview

7.4 Coherus Biosciences

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Adalimumab Biosimilar Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Coherus Biosciences Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.4.4 Main Business/Business Overview

7.5 Fujifilm Kyowa Kirin Biologics

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Adalimumab Biosimilar Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2015-2018)

7.5.4 Main Business/Business Overview

7.6 LG Life Sciences/Mochida Pharmaceutical

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Adalimumab Biosimilar Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.6.4 Main Business/Business Overview

7.7 Momenta Pharmaceuticals

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Adalimumab Biosimilar Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.7.4 Main Business/Business Overview

7.8 Oncobiologics

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Adalimumab Biosimilar Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Oncobiologics Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.8.4 Main Business/Business Overview

7.9 Pfizer

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Adalimumab Biosimilar Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Pfizer Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.9.4 Main Business/Business Overview

7.8 Samsung Bioepsis

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Adalimumab Biosimilar Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Samsung Bioepsis Adalimumab Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

7.10.4 Main Business/Business Overview

7.11 Sandoz

7.12 Zydus Cadila

8 Adalimumab Biosimilar Manufacturing Cost Analysis

8.1 Adalimumab Biosimilar Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Adalimumab Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Adalimumab Biosimilar Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2017

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Adalimumab Biosimilar Market Forecast (2018-2025)

12.1 Global Adalimumab Biosimilar Capacity, Production, Revenue Forecast (2018-2025)

12.1.1 Global Adalimumab Biosimilar Capacity, Production and Growth Rate Forecast (2018-2025)

12.1.2 Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2018-2025)

12.1.3 Global Adalimumab Biosimilar Price and Trend Forecast (2018-2025)

12.2 Global Adalimumab Biosimilar Production, Consumption , Import and Export Forecast by Region (2018-2025)

12.2.1 North America Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.2 Europe Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.3 China Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.4 Japan Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.5 Southeast Asia Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.2.6 India Adalimumab Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2018-2025)

12.3 Global Adalimumab Biosimilar Production, Revenue and Price Forecast by Type (2018-2025)

12.4 Global Adalimumab Biosimilar Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

List of Tables and Figures

Figure Picture of Adalimumab Biosimilar

Figure Global Adalimumab Biosimilar Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Adalimumab Biosimilar Production Market Share by Types (Product Category) in 2017

Figure Product Picture of Tablet

Table Major Manufacturers of Tablet

Figure Product Picture of Oral Solution

Table Major Manufacturers of Oral Solution

Figure Global Adalimumab Biosimilar Consumption (K Units) by Applications (2013-2025)

Figure Hospital Pharmacy Examples

Table Key Downstream Customer in Hospital Pharmacy

Figure Retail Pharmacy Examples

Table Key Downstream Customer in Retail Pharmacy

Figure Online Pharmacy Examples

Table Key Downstream Customer in Online Pharmacy

Figure Global Adalimumab Biosimilar Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)

Figure North America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure China Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate (2013-2025)

Figure Global Adalimumab Biosimilar Revenue (Million USD) Status and Outlook (2013-2025)

Figure Global Adalimumab Biosimilar Capacity, Production (K Units) Status and Outlook (2013-2025)

Figure Global Adalimumab Biosimilar Major Players Product Capacity (K Units) (2013-2018)

Table Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers (2013-2018)

Table Global Adalimumab Biosimilar Capacity Market Share of Key Manufacturers (2013-2018)

Figure Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers in 2017

Figure Global Adalimumab Biosimilar Capacity (K Units) of Key Manufacturers in 2018

Figure Global Adalimumab Biosimilar Major Players Product Production (K Units) (2013-2018)

Table Global Adalimumab Biosimilar Production (K Units) of Key Manufacturers (2013-2018)

Table Global Adalimumab Biosimilar Production Share by Manufacturers (2013-2018)

Figure 2017 Adalimumab Biosimilar Production Share by Manufacturers

Figure 2017 Adalimumab Biosimilar Production Share by Manufacturers

Figure Global Adalimumab Biosimilar Major Players Product Revenue (Million USD) (2013-2018)

Table Global Adalimumab Biosimilar Revenue (Million USD) by Manufacturers (2013-2018)

Table Global Adalimumab Biosimilar Revenue Share by Manufacturers (2013-2018)

Table 2017 Global Adalimumab Biosimilar Revenue Share by Manufacturers

Table 2018 Global Adalimumab Biosimilar Revenue Share by Manufacturers

Table Global Market Adalimumab Biosimilar Average Price (USD/Unit) of Key Manufacturers (2013-2018)

Figure Global Market Adalimumab Biosimilar Average Price (USD/Unit) of Key Manufacturers in 2017

Table Manufacturers Adalimumab Biosimilar Manufacturing Base Distribution and Sales Area

Table Manufacturers Adalimumab Biosimilar Product Category

Figure Adalimumab Biosimilar Market Share of Top 3 Manufacturers

Figure Adalimumab Biosimilar Market Share of Top 5 Manufacturers

Table Global Adalimumab Biosimilar Capacity (K Units) by Region (2013-2018)

Figure Global Adalimumab Biosimilar Capacity Market Share by Region (2013-2018)

Figure Global Adalimumab Biosimilar Capacity Market Share by Region (2013-2018)

Figure 2017 Global Adalimumab Biosimilar Capacity Market Share by Region

Table Global Adalimumab Biosimilar Production by Region (2013-2018)

Figure Global Adalimumab Biosimilar Production (K Units) by Region (2013-2018)

Figure Global Adalimumab Biosimilar Production Market Share by Region (2013-2018)

Figure 2017 Global Adalimumab Biosimilar Production Market Share by Region

Table Global Adalimumab Biosimilar Revenue (Million USD) by Region (2013-2018)

Table Global Adalimumab Biosimilar Revenue Market Share by Region (2013-2018)

Figure Global Adalimumab Biosimilar Revenue Market Share by Region (2013-2018)

Table 2017 Global Adalimumab Biosimilar Revenue Market Share by Region

Figure Global Adalimumab Biosimilar Capacity, Production (K Units) and Growth Rate (2013-2018)

Table Global Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table North America Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Europe Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table China Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Japan Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Southeast Asia Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table India Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Global Adalimumab Biosimilar Consumption (K Units) Market by Region (2013-2018)

Table Global Adalimumab Biosimilar Consumption Market Share by Region (2013-2018)

Figure Global Adalimumab Biosimilar Consumption Market Share by Region (2013-2018)

Figure 2017 Global Adalimumab Biosimilar Consumption (K Units) Market Share by Region

Table North America Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table Europe Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table China Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table Japan Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table Southeast Asia Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table India Adalimumab Biosimilar Production, Consumption, Import & Export (K Units) (2013-2018)

Table Global Adalimumab Biosimilar Production (K Units) by Type (2013-2018)

Table Global Adalimumab Biosimilar Production Share by Type (2013-2018)

Figure Production Market Share of Adalimumab Biosimilar by Type (2013-2018)

Figure 2017 Production Market Share of Adalimumab Biosimilar by Type

Table Global Adalimumab Biosimilar Revenue (Million USD) by Type (2013-2018)

Table Global Adalimumab Biosimilar Revenue Share by Type (2013-2018)

Figure Production Revenue Share of Adalimumab Biosimilar by Type (2013-2018)

Figure 2017 Revenue Market Share of Adalimumab Biosimilar by Type

Table Global Adalimumab Biosimilar Price (USD/Unit) by Type (2013-2018)

Figure Global Adalimumab Biosimilar Production Growth by Type (2013-2018)

Table Global Adalimumab Biosimilar Consumption (K Units) by Application (2013-2018)

Table Global Adalimumab Biosimilar Consumption Market Share by Application (2013-2018)

Figure Global Adalimumab Biosimilar Consumption Market Share by Applications (2013-2018)

Figure Global Adalimumab Biosimilar Consumption Market Share by Application in 2017

Table Global Adalimumab Biosimilar Consumption Growth Rate by Application (2013-2018)

Figure Global Adalimumab Biosimilar Consumption Growth Rate by Application (2013-2018)

Table AET BioTech Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AET BioTech Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure AET BioTech Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure AET BioTech Adalimumab Biosimilar Production Market Share (2013-2018)

Figure AET BioTech Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Amgen Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Amgen Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Amgen Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Boehringer Ingelheim Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Boehringer Ingelheim Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Boehringer Ingelheim Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Boehringer Ingelheim Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Coherus Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Coherus Biosciences Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Coherus Biosciences Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Coherus Biosciences Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Coherus Biosciences Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Production Market Share (2013-2018)

Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Momenta Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Momenta Pharmaceuticals Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Momenta Pharmaceuticals Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Momenta Pharmaceuticals Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Momenta Pharmaceuticals Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Oncobiologics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Oncobiologics Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Oncobiologics Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Oncobiologics Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Oncobiologics Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Pfizer Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Pfizer Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Samsung Bioepsis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Samsung Bioepsis Adalimumab Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Samsung Bioepsis Adalimumab Biosimilar Production Growth Rate (2013-2018)

Figure Samsung Bioepsis Adalimumab Biosimilar Production Market Share (2013-2018)

Figure Samsung Bioepsis Adalimumab Biosimilar Revenue Market Share (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Adalimumab Biosimilar

Figure Manufacturing Process Analysis of Adalimumab Biosimilar

Figure Adalimumab Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2017

Table Major Buyers of Adalimumab Biosimilar

Table Distributors/Traders List

Figure Global Adalimumab Biosimilar Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Global Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Global Adalimumab Biosimilar Price (Million USD) and Trend Forecast (2018-2025)

Table Global Adalimumab Biosimilar Production (K Units) Forecast by Region (2018-2025)

Figure Global Adalimumab Biosimilar Production Market Share Forecast by Region (2018-2025)

Table Global Adalimumab Biosimilar Consumption (K Units) Forecast by Region (2018-2025)

Figure Global Adalimumab Biosimilar Consumption Market Share Forecast by Region (2018-2025)

Figure North America Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure North America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table North America Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Asia-Pacific Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Asia-Pacific Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Asia-Pacific Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Europe Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Europe Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Europe Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Central & South America Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Central & South America Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Central & South America Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure Southeast Asia Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Southeast Asia Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Figure India Adalimumab Biosimilar Production (K Units) and Growth Rate Forecast (2018-2025)

Figure India Adalimumab Biosimilar Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table India Adalimumab Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2018-2025)

Table Global Adalimumab Biosimilar Production (K Units) Forecast by Type (2018-2025)

Figure Global Adalimumab Biosimilar Production (K Units) Forecast by Type (2018-2025)

Table Global Adalimumab Biosimilar Revenue (Million USD) Forecast by Type (2018-2025)

Figure Global Adalimumab Biosimilar Revenue Market Share Forecast by Type (2018-2025)

Table Global Adalimumab Biosimilar Price Forecast by Type (2018-2025)

Table Global Adalimumab Biosimilar Consumption (K Units) Forecast by Application (2018-2025)

Figure Global Adalimumab Biosimilar Consumption (K Units) Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370